Actinium Pharmaceuticals, Inc.
(NYSE Amex Equities : ATNM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.29%183.301.3%$478.93m
ARRYArray BioPharma Inc.
0.01%46.518.1%$426.58m
CELGCelgene Corporation
0.27%98.091.3%$407.13m
GILDGilead Sciences, Inc.
0.06%68.300.9%$393.75m
BIIBBiogen Inc.
0.31%234.631.3%$351.79m
ILMNIllumina, Inc.
0.99%355.433.5%$285.01m
REGNRegeneron Pharmaceuticals, Inc.
2.85%319.682.6%$240.04m
VRTXVertex Pharmaceuticals Incorporated
0.34%182.371.9%$217.45m
AAgilent Technologies, Inc.
0.14%72.751.6%$195.49m
EXASExact Sciences Corporation
-0.63%115.2624.1%$187.97m
ALXNAlexion Pharmaceuticals, Inc.
2.80%127.232.0%$182.95m
BMRNBioMarin Pharmaceutical Inc.
1.55%86.344.3%$129.82m
SRPTSarepta Therapeutics, Inc.
-3.04%130.3314.7%$108.96m
INCYIncyte Corporation
1.43%86.082.5%$107.96m
MRTXMirati Therapeutics Inc.
4.40%105.682.5%$102.72m

Company Profile

Actinium Pharmaceuticals, Inc. is a clinical-stage, Biopharmaceutical Company focused on developing and potentially commercializing therapies to cell therapies. The firm's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells. Its product pipeline includes Iomab-B, Actimab-A, and Actimab-M. The company was founded in 1993 and is headquartered in New York, NY.